[1]孟超 章玉冰 李勇 郑军.Quadrant通道下腰椎微创融合治疗腰椎退行性疾病86例[J].中国中医骨伤科杂志,2021,29(10):47-50.
　MENG Chao ZHANG Yubing LI Yong ZHENG Jun.86 Cases of Clinical Observation of Quadrant Channel Minimally InvasiveFusion in the Treatment of Degenerative Diseases of Lumbar Spine[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2021,29(10):47-50.
点击复制

Quadrant通道下腰椎微创融合治疗腰椎退行性疾病86例()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第29卷
期数:
2021年10期
页码:
47-50
栏目:
临床报道
出版日期:
2021-10-15

文章信息/Info

Title:
86 Cases of Clinical Observation of Quadrant Channel Minimally InvasiveFusion in the Treatment of Degenerative Diseases of Lumbar Spine
文章编号:
1005-0205(2021)10-0047-04
作者:
孟超1 章玉冰1 李勇1 郑军1
1安徽省第二人民医院脊柱外科(合肥,230032)
Author(s):
MENG Chao1 ZHANG Yubing1 LI Yong1 ZHENG Jun1
1Department of Spine Surgery,Anhui Second People’s Hospital,Hefei 230032,China.
关键词:
腰椎退行性疾病;  Quadrant通道;  腰椎微创融合术;  疗效;  安全性
Keywords:
lumbar degenerative disease;  Quadrant channel;  minimally invasive lumbar fusion;  efficacy;  safety
分类号:
R681.5
文献标志码:
B
摘要:
目的:分析Quadrant通道下腰椎微创融合术治疗腰椎退行性疾病的的疗效及安全性。方法:选取2016年11月至2019年11月收治的86例腰椎退行性疾病患者为研究对象,均采用Quadrant通道下腰椎微创融合治疗,观察并记录手术时间、术中出血量、术后下地活动时间、疼痛程度VAS评分、Oswestry功能障碍指数(ODI)、腰椎功能JOA评分、椎间隙腹侧高度、椎间隙背侧高度、椎间隙手术侧高度、体椎间融合率、邻近椎间盘退变发生率、炎性因子(C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10))及并发症发生率,并对患者进行1 a随访,记录远期效果。结果:Quadrant通道下腰椎微创融合治疗腰椎退行性疾病的手术时间为(128.23±20.67)min,术中出血量为(188.23±15.19)mL,术后下地活动时间为(3.07±0.53)d。治疗后3个月,腰椎退行性疾病患者VAS评分为(1.35±0.33)分,JOA评分为(20.16±6.15)分,ODI评分为(12.19±3.55)分; 治疗后椎间隙腹侧高度为(18.41±6.03)mm,椎间隙背侧高度为(12.68±5.19)mm,椎间隙手术侧高度为(13.67±5.12)mm; 治疗后血清CRP为(14.38±3.62)mg/L,TNF-α为(30.65±10.19)pg/mL,IL-6为(14.45±5.28)pg/mL,IL-10为(8.11±2.04)ng/mL; 治疗后VAS、ODI评分低于治疗前,JOA评分、血清炎性因子水平和椎间隙腹侧、背侧及手术侧高度均高于治疗前,差异有统计学意义(P<0.05)。椎体间融合率为95.35%,邻近椎间盘退变发生率为22.09%,并发症发生率为4.65%。术后1 a复查腰椎MRI显示,观察组保护节段的椎间盘突出均消失; 未发现邻近节段不稳; 无邻近节段退变性疾病发生。结论:Quadrant通道下腰椎微创融合治疗腰椎退行性疾病的疗效显著,可缓解疼痛程度,提高腰椎功能,降低炎性因子水平,且安全性较高,远期疗效更佳。
Abstract:
Objective:To analyze the efficacy and safety of Quadrant channel minimally invasive lumbar fusion in the treatment of degenerative diseases of the lumbar spine.Methods:86 patients with lumbar degenerative diseases from November 2016 to November 2019 were selected as the research objects,and all of them were treated with minimally invasive lumbar fusion through Quadrant channel.The operation time,intraoperative blood loss,postoperative ambulation time,VAS score,Oswestry disability index(ODI),lumbar spine function JOA score,intervertebral space ventral height,intervertebral space dorsal height,intervertebral space operative side height,intervertebral fusion rate,adjacent intervertebral disc degeneration rate,inflammatory factors(C-reactive protein(CRP)tumor necrosis factor-α(TNF-α)、interleukin-6(IL-6),interleukin-10(IL-10))and the incidence of complications were documented.Results:The operation time of minimally invasive lumbar fusion in the treatment of lumbar degenerative diseases through Quadrant channel was(128.23±20.67)min,intraoperative blood loss was(188.23±15.19)mL,postoperative ambulation time was(3.07±0.53)d.At 3 months after treatment,the VAS score,JOA score and ODI score of patients with lumbar degenerative disease were(1.35±0.33),(20.16±6.15)and(12.19±3.55)respectively.After treatment,the ventral height of the intervertebral space was(18.41±6.03)mm,the dorsal height of the intervertebral space was(12.68±5.19)mm,and the operating height of the intervertebral space was(13.67±5.12)mm.After treatment,serum CRP,TNF-α,IL-6 and IL-10 were(14.38±3.62)mg/L,(30.65±10.19)pg/mL,(14.45±5.28)pg/mL,and(8.11±2.04)ng/mL.After treatment,VAS and ODI scores were lower than before treatment,while JOA score,serum inflammatory factor level and ventral,dorsal and surgical height of intervertebral space were higher than those before treatment(P<0.05).The intervertebral fusion rate was 95.35%,the incidence of degeneration of adjacent intervertebral discs was 22.09%,and the incidence of complications was 4.65%.One year after surgery,lumbar MRI showed that the disc herniation in the observation group disappeared.No adjacent segment instability,no adjacent segmental degenerative disease was found.Conclusion:Quadrant channel minimally invasive lumbar fusion has significant efficacy in the treatment of lumbar degenerative diseases,which can relieve pain,improve lumbar function,and reduce the level of inflammatory factors,with high safety and better long-term efficacy.

参考文献/References:

[1] 石义华,周轶,晏雄伟,等.双切口Quadrant通道下微创经椎间孔椎间融合术治疗退行性腰椎疾病[J].骨科,2017,8(2):99-102.
[2] 黄群,盛晓磊,严飞,等.Quadrant通道下经椎间孔微创置入椎体间融合器治疗腰椎退行性疾病[J].中国组织工程研究,2019,23(36):5818-5823.
[3] 桂光明,曹波,张惠.Quadrant通道微创椎体间融合术和MIS-TLIF治疗腰椎退行性疾病的效果[J].齐鲁医学杂志,2017,32(6):728-731.
[4] 陈晶祥,周江军,赵敏,等.Quadrant通道微创TLIF治疗相邻双节段腰椎间盘突出症的疗效分析[J].中国骨与关节损伤杂志,2017,32(1):65-66.
[5] 孙兵,车晓明.视觉模拟评分法(VAS)[J].中华神经外科杂志,2012,28(6):645-646.
[6] 程继伟,王振林,刘伟,等.Oswestry功能障碍指数的改良及信度和效度检验[J].中国脊柱脊髓杂志,2017,27(3):50-56.
[7] 孙兵,车晓明.日本骨科协会评估治疗(JOA评分)[J].中华神经外科杂志,2013,29(9):969-970.
[8] BYVALTSEV V,KALININ A,BELYKH E,et al.Outcome analysis of direct lateral interbody fusion in the treatment of patients with degenerative disc diseases of lumbar spine[J].New Armenian Medical Journal,2017,11(1):33-39.
[9] WU A M,HU Z C,LI X B,et al.Comparison of minimally invasive and open transforaminal lumbar interbody fusion in the treatment of single segmental lumbar spondylolisthesis:minimum two-year follow up[J].Annals of Translational Medicine,2018,6(6):105-109.
[10] 殷榛,孙继芾,柯荣军,等.开放与微创经椎间孔椎体间融合术治疗单节段腰椎退行性疾病的效果比较[J].江苏大学学报(医学版),2018,28(3):259-263.
[11] 侯金龙,梅伟,宋双伟,等.双切口Quadrant通道下MIS-TLIF与TLIF治疗腰椎退行性病变的回顾性对照研究[J].颈腰痛杂志,2018,39(5):105-107.
[12] 刘齐元,张大伟,崔威,等.Quadrant通道下MIS-TLIF与传统术式治疗单节段腰椎退变性疾病的疗效比较[J].现代生物医学进展,2017,17(20):3957-3960.
[13] 闫骏宏,黄媛霞,徐海斌,等.Quadrant通道下微创经椎间孔椎体间融合与开放经椎间孔椎体间融合治疗腰椎退行性疾病的疗效比较[J].新乡医学院学报,2018,35(3):212-215.
[14] 张岱阳,尹锐,胡睿,等.神经妥乐平联合Quadrant通道下精准治疗对退变性腰椎管狭窄症患者腰椎功能及血清炎症因子的影响[J].中国医师杂志,2020,22(6):919-922.
[15] 秦超,熊健,文文,等.微创及开放经椎间孔腰椎椎体融合手术下腰椎退行性疾病患者的血清炎性因子与感染状况对比[J].中国老年学杂志,2020,40(6):1248-1251.

更新日期/Last Update: 1900-01-01